Beacon Therapeutics’ AGTC-501 holds potential to become first gene therapy in XLRP space: GlobalData GlobalData Jun 20, 2024 AGTC-501 is highly anticipated as having the potential to become the first gene therapy specifically indicated for X-linked…
